The effect of COX-2 inhibitor on bladder cancer

王春荣,林宗明,陈耀武
DOI: https://doi.org/10.3969/j.issn.1009-8291.2009.02.010
2009-01-01
Abstract:Objective To study the inhibiting effects of celecoxib on mice bladder cancer and investigate the mechanism.Methods Models were established with T739 mice and BTT739 cell line.Mice were randomly divided into the control group(CG)and the test group(TG),with 10 in each one.From the second day after operation,celecoxib in suspension at 20 mg/kg was administered to mice in TG orally,while saline to the mice in the CG.During the test,the growth of tumor mass was observed and the growth curve was drawn.4 weeks later,the mice were to resect tumors,compare their weight and conduct routine pathology examination.The expression of COX-2 and VEGF was observed with immunohistochemistry.Results The mean weight of test group was(1.10±0.52)g,control group(3.27±1.89)g,which was significant in statistics(P0.05).The difference of latent period between TG and CG was not significant statistically [(7.10±2.28)d vs.(7.20±2.71)d](P0.05).The growth curve showed that there was difference in tumor volume between CG and TG,and it lasted to the end of the test.Pathologically,large necrosis area could be seen in TG,while not in CG.In immunohistochemistry,COX-2 and VEGF were positive in cell plasma and/or cell membrane.The expression of COX-2 and VEGF in TG was statistically different from that in CG(P0.05 or P0.01).And there was a positive correlation between the expression of COX-2 and VEGF.Conclusion Celecoxib inhibits COX-2 to constrain angiogenesis so as to restrain bladder cancer.
What problem does this paper attempt to address?